| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH |
|
|
|
|||||||
|
|||||||||
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
1 Cardiovascular Center, Medical College of Wisconsin, Milwaukee, WI, USA
2 VA Medical Center, Milwaukee, WI, USA
3 Midwest Heart Surgery Institute, Milwaukee, WI, USA
4 2nd Department of Internal Medicine, Akita University, Akita City, Akita, Japan
* To whom correspondence should be addressed. E-mail: dgutt{at}mcw.edu.
Thrombin (THR), activated as part of the clotting cascade, dilates conduit arteries through an endothelial pertussis toxin (PTX)-sensitive G-protein receptor and releases nitric oxide (NO). THR also acts on downstream microvessels. Therefore, we examined whether THR dilates human coronary arterioles (HCA). HCA from right atrial appendages were constricted by 30-50% with endothelin-1. Dilation to THR (10-4 to 1 U/ml) was assessed before and after inhibitors with videomicroscopy. There was no tachyphylaxis to THR dilation (max dilation = 87.0%, ED50 = 1.49x10-2). Dilation to THR was abolished with either hirudin or denudation but was not affected by PTX. Neither L-NAME (n=7), INDO (n=9), ODQ (n=6), TEA (n=5) nor IBTX (n=4), reduced dilation to THR. However, KCl (max dilation=89±5vs.20±10%,p<0.05,n=7), TBA (max dilation=79±7vs.21±4%,p<0.05,n=5), and CTX (max dilation=89±4vs.10±2%,p<0.05,n=4) attenuated dilation to THR. In contrast to animal models, THR-induced dilation in human arterioles is independent of Gi-protein activation or NO release. However, THR dilation is endothelial dependent, is maintained on consecutive applications, and involves activation of potassium channels. We speculate that an endothelium derived hyperpolarizing factor contributes to thrombin-induced dilation in HCA.
This article has been cited by other articles:
|
|
 |
|
  J. L. Strande, M. E. Widlansky, N. E. Tsopanoglou, J. Su, J. Wang, A. Hsu, K. V. Routhu, and J. E. Baker Parstatin: a cryptic peptide involved in cardioprotection after ischaemia and reperfusion injury Cardiovasc Res, July 15, 2009; 83(2): 325 - 334. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 O. A. Hatoum, K. M. Gauthier, D. G. Binion, H. Miura, G. Telford, M. F. Otterson, W. B. Campbell, and D. D. Gutterman Novel Mechanism of Vasodilation in Inflammatory Bowel Disease Arterioscler Thromb Vasc Biol, November 1, 2005; 25(11): 2355 - 2361. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. Sato, K. Terata, H. Miura, K. Toyama, F. R. Loberiza Jr., O. A. Hatoum, T. Saito, I. Sakuma, and D. D. Gutterman Mechanism of vasodilation to adenosine in coronary arterioles from patients with heart disease Am J Physiol Heart Circ Physiol, April 1, 2005; 288(4): H1633 - H1640. [Abstract] [Full Text] [PDF]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH |
| Visit Other APS Journals Online |
